SHANNON KNAPP: Open Payments
NPI 1144583477 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 79 payments from 17 companies in 2025. Trend: 2023 $80 · 2024 $1,353 · 2025 $1,743
Food & beverage: $1,743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $457 |
| Novo Nordisk Inc | 5 | $203 |
| ABBVIE INC. | 9 | $202 |
| Otsuka America Pharmaceutical, Inc. | 14 | $145 |
| Amgen Inc. | 5 | $98 |
| SHIELD THERAPEUTICS INC | 3 | $74 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Lilly USA, LLC | 3 | $71 |
| Lundbeck LLC | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: AIRSUPRA, REXULTI, Wegovy, VRAYLAR, ACCRUFER, Auvelity, CAPLYTA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
